Hepatitis B Reactivation in a HBsAg-Negative, HBcAb-Positive Patient Receiving Fludarabine for the Treatment of Chronic Lymphocytic Leukaemia

Hepatitis B virus (HBV) reactivation is an increasingly recognized cause of morbidity and mortality in patients undergoing chemotherapy. In haematology, the risk of reactivation of B hepatitis among HBsAg-positive patients has been documented; therefore, use of lamivudine prophylaxis is recommended...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Case Reports Hepatol
Main Authors: Toscanini, Federica, De Leo, Pasqualina, Calcagno, Giuseppe, Malfatti, Federica, Grasso, Alessandro, Anselmo, Marco
Formáid: Artigo
Teanga:Inglês
Foilsithe: Hindawi Publishing Corporation 2011
Ábhair:
Case Report
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4411891/
https://ncbi.nlm.nih.gov/pubmed/25954538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/258791
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla